AKAP9 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.995600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.840600E-01
Normal-vs-Stage2
6.562400E-01
Normal-vs-Stage3
4.588000E-02
Normal-vs-Stage4
9.631200E-01
Stage1-vs-Stage2
2.112000E-01
Stage1-vs-Stage3
6.462200E-02
Stage1-vs-Stage4
4.231000E-01
Stage2-vs-Stage3
4.385200E-04
Stage2-vs-Stage4
5.742200E-01
Stage3-vs-Stage4
1.495960E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.195800E-01
Normal-vs-AfricanAmerican
9.281600E-01
Normal-vs-Asian
4.815000E-01
Caucasian-vs-AfricanAmerican
6.554800E-01
Caucasian-vs-Asian
4.422000E-01
AfricanAmerican-vs-Asian
3.290600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.075400E-01
Normal-vs-Female
7.976400E-01
Male-vs-Female
9.148200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.427400E-01
Normal-vs-Age(41-60Yrs)
7.898800E-01
Normal-vs-Age(61-80Yrs)
5.190000E-01
Normal-vs-Age(81-100Yrs)
7.924800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.780000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.299180E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.293200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.276600E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.935600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.697400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.598200E-01
Normal-vs-Daily Drinker
4.006200E-01
Normal-vs-Weekly Drinker
1.674410E-01
Normal-vs-Occasional Drinker
9.300200E-01
Normal-vs-Social Drinker
8.382400E-01
Non Drinker-vs-Daily Drinker
8.436400E-01
Non Drinker-vs-Weekly Drinker
2.491600E-01
Non Drinker-vs-Occasional Drinker
2.136000E-01
Non Drinker-vs-Social Drinker
1.643230E-01
Daily Drinker-vs-Weekly Drinker
2.565800E-01
Daily Drinker-vs-Occasional Drinker
1.784780E-01
Daily Drinker-vs-Social Drinker
1.835180E-01
Weekly Drinker-vs-Occasional Drinker
5.294400E-02
Weekly Drinker-vs-Social Drinker
5.776300E-02
Occasional Drinker-vs-Social Drinker
8.008600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.015410E-01
Normal-vs-Grade 2
1.865900E-02
Normal-vs-Grade 3
6.176800E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.835600E-02
Grade 1-vs-Grade 3
2.806200E-01
Grade 1-vs-Grade 4
1.015410E-01
Grade 2-vs-Grade 3
1.950160E-01
Grade 2-vs-Grade 4
1.865900E-02
Grade 3-vs-Grade 4
6.176800E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.131200E-01
Normal-vs-NonDiabetic
7.822200E-01
Diabetic-vs-NonDiabetic
7.424100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.039400E-01
Normal-vs-NoPancreatitis
7.151200E-01
Pancreatitis-vs-NoPancreatitis
1.884000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.515800E-01
Normal-vs-N1
6.507800E-01
N0-vs-N1
4.110000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.227400E-01
Normal-vs-TP53-NonMutant
6.422600E-01
TP53-Mutant-vs-TP53-NonMutant
2.697100E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
